Global virtual reality (VR) in the gaming market was valued at $31.7 billion in 2024 and is growing at a CAGR of 27.2% during the forecast period (2026-2035). Demand for portable immersive gaming experiences is rising as gamers prefer flexibility beyond fixed setups. Lightweight, wearable display solutions facilitate large-screen gaming anywhere, aligning with the mobile and hybrid gaming ecosystem trend, thereby driving market growth. Recent advancements in high-refresh, micro-display technologies have made it possible to deliver large virtual screens in compact, wearable formats, combining portability with premium visual performance. For instance, in January 2026, the ROG XREAL R1 gaming glasses offer a portable solution for gamers seeking a 171-inch virtual screen with a 240Hz refresh rate. It provides a lightweight display ideal for on-the-go gaming with devices like the ROG Xbox Ally, or as an additional monitor in cramped setups. Featuring the world's first 240Hz micro-OLED FHD technology, the glasses deliver vibrant visuals suitable for both AAA titles and competitive multiplayer games. With a 57° field of view, users experience a spacious virtual environment, akin to viewing a large screen from a distance, ensuring immersive gameplay and entertainment. The glasses also include a mode called Anchor Mode, allowing the virtual screen to stabilize for standard display usage.

US smart transportation market was valued at $2.15 billion in 2025 and is projected to reach $4.8 billion by 2035, growing at a CAGR of 8.6% during the forecast period (2026–2035). The acceleration of smart transportation in the US is increasingly driven by the deployment of Intelligent Transportation Systems (ITS) technologies across roadways and transit networks. Official data from the 2023 ITS Deployment Tracking Survey shows that transportation agencies are expanding the use of digital and connected systems that directly impact traffic management, traveler information, and fare payment operations nationwide. This systematic expansion is enhancing operational capabilities, improving commuter experience and safety, and laying the groundwork for broader multimodal integration across rail, road, and transit services. 

Global dental care equipment market was valued at $10.1 billion in 2025 and is growing at a CAGR of 5.8% during the forecast period (2026-2035). Rising adoption of digital dentistry solutions, particularly digital imaging, 3D scanning, and CAD/CAM technologies, is driving market growth for advanced dental equipment. This trend is reflected in the increasing emphasis on clinical education, research, and evidence-based practices within the dental industry. For instance, in September 2025, Align Technology, Inc. specializes in the design and manufacture of the Invisalign System, iTero intraoral scanners, and exocad CAD/CAM software, contributing to advancements in digital orthodontics and restorative dentistry. At its Global Faculty Meeting, over 100 trained doctor educators participated in extensive workshops on the latest innovations and clinical evidence related to Invisalign and iTero solutions. The event also highlighted the launch of a new clinical evidence webpage with 800+ peer-reviewed publications and an expanded Align Global Gallery showcasing over 1,500 case studies, alongside the announcement of more than $4 million in grants for orthodontic and dental research.

The UK smart transportation market stood at USD 0.55 billion in 2025 and is expected to grow to USD 1.05 billion by 2035, registering a compound annual growth rate of 6.6% from 2026 to 2035. The expansion of digital ticketing and integrated transport systems is a key driver shaping the UK’s smart transportation landscape. Government efforts to modernise fare collection, simplify access, and improve multimodal connectivity are influencing how people use services across rail, bus, and urban networks. This drive is closely tied to broader transport reform goals set out by the Department for Transport, which include improving public transport reliability and enabling seamless journey experiences for passengers. 

UK cloud database and DBaaS market was valued at $1.6 billion in 2025 and is projected to reach $7.3 billion by 2035, growing at a CAGR of 16.6% during the forecast period (2026–2035). The rapid uptake of cloud computing across UK businesses and public sector organisations is a major driver of growth for cloud database and database?as?a?service (DBaaS) offerings. As firms and institutions increasingly move core computing, storage and application workloads to cloud environments, demand for scalable, flexible and managed database services rises accordingly. Broad cloud adoption reduces barriers to deploying cloud databases, supports hybrid and multi?cloud strategies and enables organisations to modernise legacy systems.

Global bladder cancer market was valued at $5,920 million in 2025 and is growing at a CAGR of 6.4% during the forecast period (2026-2035). Active interactions with regulatory agencies and streamlined submission pathways promote the market growth of innovative therapies by enabling quicker market entry. This trend is reflected in ongoing regulatory engagements that focus on optimizing approval processes and facilitating access to advanced treatment options for patients with unmet medical needs. For instance, in January 2026, ImmunityBio is in talks with the FDA about possibly resubmitting its supplemental Biologics License Application (sBLA) for ANKTIVA to treat BCG-unresponsive papillary non-muscle invasive bladder cancer (NMIBC). The FDA requested additional information, which does not require new clinical trials, to aid in their evaluation, with the company set to provide this data within 30 days. Long-term studies have indicated a 96% bladder cancer-specific survival rate and over 80% bladder preservation at three years among 80 patients. ANKTIVA has been launched in the US, along with expanded approvals in the UK and Saudi Arabia, and conditional EU approval. Recent discussions with the FDA highlighted high disease-specific survival rates and a favorable safety profile, addressing current treatment standards and challenges faced by BCG-unresponsive patients.

North America biological data visualization market stood at $281.5 million in 2025 and is expected to expand to $665.6 million by 2035, registering a CAGR of 9.1% over the 2026 to 2035 period. AI-driven analytics and scalable cloud platforms are transforming biological data visualization workflows across North America. Research groups, pharmaceutical and biotech organizations, and academic labs are increasingly adopting tools that embed machine learning and cloud-native capabilities directly into visualization systems. These technologies automate pattern recognition, accelerate interpretation of complex datasets such as single-cell profiles and multiomic outputs, and enable collaboration across distributed teams.

North America cloud database and DBaaS market was valued at $10.3 billion in 2025 and is projected to reach $49.8 billion by 2035, growing at a CAGR of 17.1% during the forecast period (2026–2035). North American enterprises are increasingly adopting multi-model and cloud-native database solutions to meet the demands of modern applications, AI workloads, and real-time analytics. Organizations across BFSI, IT, healthcare, and retail are moving beyond traditional relational databases to integrate document, vector, and key-value databases within cloud and hybrid architectures. This shift allows businesses to handle diverse workloads efficiently, scale rapidly, and ensure compliance while supporting advanced analytics and AI initiatives.

The North America smart transportation market stood at $2.9 billion in 2025 and is expected to expand to $6.5 billion by 2035, registering a CAGR of 8.6% over the 2026 to 2035 period. North America’s smart transportation landscape is being reshaped by public sector investment in intelligent systems that use real-time data and digital tools to manage traffic, reduce congestion, and improve mobility. Federal programs such as the U.S. Department of Transportation’s ITS4US Deployment Program are funding multimodal projects that integrate connected vehicle technology, adaptive signal control, and data platforms to support scalable, connected transit networks. 

Global biosensors market was valued at $34.4 billion in 2025 and is growing at a CAGR of 9.6% during the forecast period (2026-2035). Technological advancements in biosensing increasingly focus on multi-molecule detection platforms, enabling the simultaneous and continuous monitoring of multiple biomarkers in real time. These platforms improve diagnostic depth and support more comprehensive physiological insights compared to single-analyte sensors. Market growth is further driven by sensor miniaturization, which allows minimally invasive or pain-free applications, along with AI-enabled analytics that enhance data interpretation, trend prediction, and clinical relevance. In parallel, smartphone integration has become a critical enabler, improving device accessibility, user engagement, and real-time data transmission within digital health ecosystems.